The Gut-Brain Axis

Niall Hyland is a Senior Lecturer in the Department of Physiology at University College Cork in Ireland and a Funded Investigator at APC Microbiome Ireland. Dr Hyland has over 20 years’ experience in gastrointestinal physiology and enteric neuroscience and his fields of interest include enteric physiology and pharmacology, the brain-gut axis, and microbiota-host interactions. He received a BSc (Hons) in Biomedical Sciences from the University of Ulster and PhD in Pharmacology from King’s College London. Dr. Hyland was a visiting fellow at the Department of Pharmacology and Experimental Therapeutics, Louisiana State University Medical Center, USA and completed postdoctoral training at the University of Calgary, Canada. He returned to Ireland in 2007. He has represented Ireland on the Steering Committee of the European Society of Neurogastroenterology and Motilty and is an Honorary Fellow of the British Pharmacological Society.Catherine Stanton is a Senior Principal Research Officer at Teagasc Moorepark Food Research Centre, Moorepark, Fermoy, Ireland, a Research Professor at University College Cork, College of Medicine and Health, and one of the original PI of APC Microbiome Ireland. Her research program addresses development of innovative dairy foods and probiotics that influence human health and the developing gut microbiota in early life. She has led numerous national and international grants, including the coordination of a number EU projects on various aspects of probiotics for human and animal applications.

• 1. Global and Epidemiological Perspectives on Diet and Mood2. Targeting the microbiota: Considerations for developing probiotics as functional foods3. Food- and non-food based strategies for effective delivery of probiotics4. Bioactive- and non-bioactive food constituents and their influence on the microbiome5. Correlating the gut microbiome to health and disease6. The microbiome and aging: Impact on health and wellbeing7. Importance of the microbiota in early life and influence on future health8. Utility of microbial genome sequencing in probiotic strain identification: Promises and pitfalls9. Germ-Free Animals: A Key Tool in Unravelling How the Microbiota Affects Brain and Behavior10. Sensitivity of the hypothalamic-pituitary-adrenal axis to the gut microbiota: Opportunities for dietary intervention11. A neuroactive microbiome12. The influence of diet and the gut microbiota in schizophrenia13. Influence of the microbiota on the development and function of "the second brain" - the enteric nervous system 14. Dietary inventions and brain-gut disorders15. Altering the gut microbiome for cognitive benefit?16. The role of the microbiota in neurodevelopmental disorders17. The role of the microbiota and potential for dietary intervention in chronic fatigue syndrome18. Potential for pre - and probiotics in managing psychological symptoms associated with alcohol-dependence19. Where next for dietary intetventions and the brain-gut axis?20. Perspectives on targeting the microbiome in developing global populations21. Regulatory considerations for the use and marketing of probiotics and functional foods22. Microbiota and Metabolism